Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 7, 1998

View Archived Issues

Trinity Biotech Acquires Selfcare Line For US$4.5M

Gemini, Chiroscience Group Partner For Obesity Genes

Canada's NRC Joining Effort To Oversee Genomics Research

Challenge To Monsanto Quashed In High Court

Mutated-Gene Culprit That Causes Duncan Disease Located By Researchers

Elan Aiming At Oncology In $130M Deal With Ligand

Oxagen Enters Astra Deal For Atherosclerosis Genes

Oxford Biomedica Signs Pair Of Research Deals

UCL Spin-Out Inpharmatica Blends Computers, Genomics

Prolifix Ousts CEO Lewis After Less Than One Year

European Confusion Deepens In Controversy Over GMOs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...